Clinical Trial Update: Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metoprolol succinate for cardiac remodeling associated with cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Cirrhotic Cardiomyopathy

Drugs mentioned

• Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

Sponsor: University of Sao Paulo | Conditions: Cirrhosis, Cirrhotic Cardiomyopathy | Phase 3 | Status: COMPLETED